BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2009
View Archived Issues
Threitol ceramide, an agonist of invariant NKT cells, may be used as vaccine adjuvant
Read More
New triptorelin 6-month formulation safe and efficacious in prostate cancer patients
Read More
Novel histone deacetylase inhibitors presented by ArQule
Read More
Combining PARP and DNA topoisomerase I inhibitor causes increased toxicity in cancer patients
Read More
PSA failures less common with degarelix than with leuprolide in phase III trial
Read More
Pfizer provides pipeline update in high-priority disease areas
Read More
BTG presents update on clinical development activities for year ended March 2009
Read More
Recent GSK patents describe novel Akt inhibitors for cancer treatment
Read More
Roche describes novel TAAR1 ligands and their use as antidepressants
Read More
New compounds for the treatment of diabetes reported by Boehringer Ingelheim
Read More
Potassium channel modulators in early development at Valeant for the treatment of epilepsy
Read More
Novel beta-secretase inhibitor shows activity in mouse model of Alzheimer's disease
Read More
FDA Advisory Committee discusses liraglutide for the treatment of type 2 diabetes
Read More
Pharmos provides update on phase II dextofisopam trial
Read More
Traversa Therapeutics' Series B financing to fund RNAi oncology programs
Read More
NIH grant to fund study of Cerashield coating in orthopedic implants
Read More
OXI-4503 begins phase Ib/IIa study in solid tumors with hepatic involvement
Read More
PPD expands its compound partnering program into dermatology
Read More
NDA for Zegerid tablet accepted for filing
Read More
KS-C370G shows cardioprotective activity in rat model of type 1 diabetes
Read More
Japanese launch for Recalbon/Bonoteo Tablets
Read More
Patient achieves insulin independence with Diabecell in phase I/IIa trial
Read More
AstraZeneca receives FDA complete response on Symbicort for pediatric asthma
Read More
Capstone initiates dosing in phase II AZX-100 pilot study in keloid scarring
Read More
Eisai enters into agreement with Nobelpharma for Gliadel Wafer
Read More